drugset / Trial / NCT05719012
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Long COVID-19
RandomizedParallel-groupTriple-blindTreatment
Summary
To explore the efficacy and safety of Umbilical cord mesenchymal stem cells in the treatment of long COVID-19
Timeline
- Start
- 2023-04-01
- Primary completion
- 2023-12-01
- Completion
- 2024-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | — | Intravenous |